Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004912 · ClinicalTrials.gov registry record · Phase 2
Megestrol and Exercise in Treating Patients With Cancer-Related Weight Loss
A Phase 2 study, sponsored by Northwestern University.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00004912: Completed Phase 2 study, sponsored by Northwestern University.
NCT00004912 is a Phase 2 study that has completed, run by Northwestern University. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00004912, a Phase 2 study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Megestrol helps improve appetite. Exercise may decrease cancer-related fatigue, improve strength, and build up lost muscle tissue. Exercise plus megestrol may be effective treatment for cancer-related weight loss. PURPOSE: Phase II trial to study the effectiveness of megestrol plus exercise to improve appetite, increase strength, gain lean body tissue, and decrease fatigue in patients who have cancer-related weight loss.
Interventions
- DRUG megestrol acetate
- PROCEDURE physical therapy
Trial Details
| Field | Value |
|---|---|
| Start Date | 2000-01 |
| Est. Completion | 2003-11 |
| Phase | Phase 2 |
What the finished NCT00004912 record still lists
NCT00004912 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which megestrol acetate is the first listed.
NCT00004912 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00004912 about?
NCT00004912 is a clinical study titled "Megestrol and Exercise in Treating Patients With Cancer-Related Weight Loss". RATIONALE: Megestrol helps improve appetite. Exercise may decrease cancer-related fatigue, improve strength, and build up lost muscle tissue. Exercise plus megestrol may be effective treatment for cancer-related weight loss. PURPOSE: Phase II trial to study the effectiveness of megestrol plus exerc...
What is the current status of trial NCT00004912?
This trial is currently completed. It is a Phase 2 study. The study started on 2000-01. Estimated completion is 2003-11.
What interventions are being tested in trial NCT00004912?
The interventions under investigation include: megestrol acetate (DRUG), physical therapy (PROCEDURE).
Who is sponsoring clinical trial NCT00004912?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia